calcium antacid tablet chewable
mckesson - calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb, carbonate ion - unii:7ujq5ope7d) - calcium carbonate 500 mg
careone calcium antacid- calcium carbonate tablet, chewable
american sales company - calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb, carbonate ion - unii:7ujq5ope7d) - calcium carbonate 1000 mg - antacid relieves presently taking a prescription drug. antacids may interact with certain prescription drugs.
antacid and anti-gas chew- calcium carbonate tablet, chewable
meijer - calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb), dimethicone (unii: 92ru3n3y1o) (dimethicone - unii:92ru3n3y1o) - calcium carbonate 750 mg - purpose antacid anti-gas uses: relieves heartburn sour stomach acid indigestion upset stomach associated with these symptoms bloating, pressure or stuffed feeling commonly referred to as gas
assorted fruit panned chew- calcium carbonate tablet, chewable
heb - calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb) - calcium carbonate 750 mg - purpose antacid uses: relieves heartburn sour stomach acid indigestion upset stomach due to these symptoms
plus pharma calcium antacid- calcium carbonate tablet, chewable
gemini pharmaceuticals, inc. dba plus pharma - calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb) - calcium carbonate 500 mg - antacid for the relief of - heartburn - sour stomach - acid indigestion - upset stomach associated with these symptoms
calcid antacid calcium supplement regular strength- calcium carbonate tablet, chewable
pro-ventas s.a. de c.v. - calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb, carbonate ion - unii:7ujq5ope7d) - calcium carbonate 500 mg
calcium acetate capsule
avkare, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate, usp is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). - patients with hypercalcemia. patients with hypercalcemia. pregnancy category c calcium acetate capsules contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1) ] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects
calcium acetate capsule
american health packaging - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c : calcium acetate capsules contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of c
calcium acetate capsule
precision dose, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate, usp is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unkno
calcium acetate capsule
zydus pharmaceuticals usa inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate capsule is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery